Address:3-25-23 Tonomachi, Kawasaki, Japan Zipcode 210-0821
Phone:81 4 4270 1300
Total Assets:26.27 B
Total Cash:7.15 B
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company uses its Peptide Discovery Platform System platform for the development of peptides. PeptiDream Inc. has a collaboration with Merck & Co. Inc. for the discovery and development of peptide therapeutics capable of neutralizing the SARS-CoV-2 virus (COVID19) and potential coronavirus outbreaks; and a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was founded in 2006 and is headquartered in Kawasaki, Japan.
|Dr. Patrick Crawford Reid Ph.D.||Pres, CEO & Representative Director||N/A||1975(45 years old)|
|Toshiyuki Iwata||Head of Investor Relations||N/A||N/A|
|Dr. Keiichi Masuya||Exec. VP & Director||N/A||1969(51 years old)|
|Dr. Kiyofumi Kaneshiro Ph.D.||Exec. VP & Director||N/A||N/A|
PeptiDream Inc. (4587.T)
|Bid||5,320.00 x N/A|
|Ask||5,350.00 x N/A|
|52 Week Range||4,135.00-6,540.00|
|Dividend (Yield %)||N/A|
Site Inspections: http://www.peptidream.com
Unable to get host informations!!!